![](/img/cover-not-exists.png)
Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
Davies, Michael J, Merton, Katherine W, Vijapurkar, Ujjwala, Balis, Dainius A., Desai, MehulVolume:
Volume 10
Language:
english
Journal:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
DOI:
10.2147/dmso.s126291
Date:
January, 2017
File:
PDF, 1.56 MB
english, 2017